Iterum Therapeutics plc (ITRM)
Total Valuation
ITRM has a market cap or net worth of $21.36 million. The enterprise value is $5.03 million.
Market Cap | 21.36M |
Enterprise Value | 5.03M |
Important Dates
The next confirmed earnings date is Thursday, March 28, 2024, before market open.
Earnings Date | Mar 28, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ITRM has 13.42 million shares outstanding. The number of shares has increased by 6.59% in one year.
Shares Outstanding | 13.42M |
Shares Change (YoY) | +6.59% |
Shares Change (QoQ) | +0.75% |
Owned by Insiders (%) | 1.85% |
Owned by Institutions (%) | 9.20% |
Float | 11.99M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 6.22 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 5.71.
Current Ratio | 2.35 |
Quick Ratio | n/a |
Debt / Equity | 5.71 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -31.37 |
Financial Efficiency
Return on equity (ROE) is -216.30% and return on invested capital (ROIC) is -190.94%.
Return on Equity (ROE) | -216.30% |
Return on Assets (ROA) | -57.70% |
Return on Capital (ROIC) | -190.94% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.22M |
Employee Count | 14 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ITRM has paid $572,000 in taxes.
Income Tax | 572,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.15% in the last 52 weeks. The beta is 2.35, so ITRM's price volatility has been higher than the market average.
Beta (1Y) | 2.35 |
52-Week Price Change | +69.15% |
50-Day Moving Average | 1.56 |
200-Day Moving Average | 1.25 |
Relative Strength Index (RSI) | 54.05 |
Average Volume (30 Days) | 611,801 |
Short Selling Information
The latest short interest is 1.21 million, so 9.00% of the outstanding shares have been sold short.
Short Interest | 1.21M |
Short Previous Month | 975,307 |
Short % of Shares Out | 9.00% |
Short % of Float | 10.07% |
Short Ratio (days to cover) | 5.63 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -43.96M |
Pretax Income | -30.53M |
Net Income | -31.10M |
EBITDA | -27.84M |
EBIT | -29.58M |
Earnings Per Share (EPS) | -$2.44 |
Balance Sheet
The company has $35.93 million in cash and $19.59 million in debt, giving a net cash position of $16.33 million or $1.22 per share.
Cash & Cash Equivalents | 35.93M |
Total Debt | 19.59M |
Net Cash | 16.33M |
Net Cash Per Share | $1.22 |
Equity / Book Value | 3.43M |
Book Value Per Share | 0.26 |
Working Capital | 22.13M |
Cash Flow
In the last 12 months, operating cash flow was -$30.75 million and capital expenditures -$58,000, giving a free cash flow of -$30.81 million.
Operating Cash Flow | -30.75M |
Capital Expenditures | -58,000 |
Free Cash Flow | -30.81M |
FCF Per Share | -$2.36 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ITRM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.59% |
Shareholder Yield | -6.59% |
Earnings Yield | -145.58% |
FCF Yield | -144.23% |
Analyst Forecast
The average price target for ITRM is $6.00, which is 277.36% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $6.00 |
Price Target Difference | 277.36% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 18, 2022. It was a reverse split with a ratio of 1:15.
Last Split Date | Aug 18, 2022 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |